Seth Klarman
Baupost Group
Baupost Group Portfolio 13F
Seth Klarman Holdings Activity
- Portfolio value:
- $8.75B≈ (+$260M≈)
- Previous value:
- $8.49B≈
- # of changes:
- 21
- New positions:
- 4
- Reported for:
- 30 Jun 2017 (Q2)
- Latest filing date:
- 11 Aug 2017
Baupost Group has disclosed a total of 21 changes to the portfolio in the (2017 Q2) SEC report(s): increased the number of shares of 7, bought 4 totally new, decreased the number of shares of 4 and completely sold out 6 position(s).
What stocks did Seth Klarman buy in 2017 Q2?
During 2017 Q2 Seth Klarman has bought 11 securities out of which top 5 purchases (by % change to portfolio) were (SYF) Synchrony Financial (added shares +65.84%), (QRVO) Qorvo Inc (added shares +25.25%), (AR) Antero Resources Corp (added shares +45.95%), (ESRX) Express Scripts Holding Co (added shares +108.11%) and (CAH) Cardinal Health Inc (added shares +97.09%).
21 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Avis Budget Group Inc
|
new
|
$27.27
|
+414.41%($140.28)
|
1.25%
|
2017 Q2
|
≈ 0.25 years
|
||||
|
|
Silver Run Acquisition Corp II, CL-A
|
new
|
$10.13
|
|
0.77%
|
2017 Q2
|
≈ 0.25 years
|
||||
|
|
Silver Run Acquisition Corp II
|
new
|
$1.79
|
|
0.05%
|
2017 Q2
|
≈ 0.25 years
|
||||
|
|
SPIRIT REALTY CAPITAL, INC
|
new
|
$37.05
|
|
0.76%
|
2017 Q2
|
≈ 0.25 years
|
||||
|
|
Express Scripts Holding Co
|
+108.11%
|
$63.84
|
|
1.86%
|
2017 Q1
|
≈ 0.50 years
|
||||
|
|
Cardinal Health Inc
|
+97.09%
|
$77.92
|
+201.75%($235.12)
|
1.81%
|
2016 Q4
|
≈ 0.75 years
|
||||
|
|
Synchrony Financial
|
+65.84%
|
$29.82
|
+166.20%($79.38)
|
9.98%
|
2016 Q3
|
≈ 1.00 year
|
||||
|
|
Antero Resources Corp
|
+45.95%
|
$21.61
|
+65.02%($35.66)
|
5.23%
|
2014 Q3
|
≈ 3.00 years
|
||||
|
|
Qorvo Inc
|
+25.25%
|
$63.32
|
+49.07%($94.39)
|
6.51%
|
2017 Q1
|
≈ 0.50 years
|
||||
|
|
Paratek Pharmaceuticals Inc
|
+17.12%
|
$24.10
|
|
0.66%
|
2014 Q4
|
≈ 2.75 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.